# A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

> **NCT00671502** · PHASE3 · COMPLETED · sponsor: **Meda Pharmaceuticals** · enrollment: 840 (actual)

## Conditions studied

- Lower Back Pain

## Interventions

- **DRUG:** Carisoprodol SR
- **DRUG:** Carisoprodol SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00671502
- **Lead sponsor:** Meda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2011-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671502, "A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00671502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*